H.R. 5926
Referred to CommitteeNaloxone Guidelines Act of 2018
Introduced 5/23/2018•115th Congress•House
Latest Action
Referred to the House Committee on Energy and Commerce.
5/23/2018 • House
Summary
Naloxone Guidelines Act of 2018
This bill requires the Department of Health and Human Services to issue guidelines for prescribing an opioid overdose reversal drug (e.g., naloxone).
The guidelines must address issues relating to the distribution, education, and safety of opioid overdose reversal drugs, including:
- co-prescription with an opioid;
- safe dosages;
- prescription for non-patients; and
- standing orders (i.e., orders that allow dispensing without a prescription).
Introduced in House • 5/23/2018
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Drug therapyDrug, alcohol, tobacco useHealth promotion and preventive careHealth technology, devices, suppliesPrescription drugs
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (2)
Party Breakdown
1
Democrats
1
Republicans
0
Independents
Sponsor
R[
Cosponsors (1)
R[
Bill Journey
Originated in the House
Introduced
May 23, 2018
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House5/23/2018